An observational study in Personalized Medicine in Type 1 Diabetes, sponsored by Dr. Orit Hamiel. Status unknown. Open to participants aged 2 Years and older. Per ClinicalTrials.gov, last updated 2016-09-29.
Sponsored by Dr. Orit Hamiel · Observational
Personalized medicine methods in the management of type 1 diabetes
This proposal joins together clinical practitioners, biologists, and computer scientists to set up the infrastructure for research that will facilitate, for the first time, the use of big-data, machine-learning approaches in the application of personalized medicine methods in the management of type 1 diabetes mellitus. We will model the clinical, microbial, and nutritional factors underlying the variability in glycemic response to food in this population; develop algorithms for prediction of this response and for the accurate administration of insulin, assisting the clinical management of the disease and discover intervention targets in the gut microbiome aimed at improving glycemic control.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's planned enrollment of 200 is below the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →Dr. Orit Hamiel is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Type 1 diabetes
over one year of diagnostic with T1DM.
Exclusion Criteria:
Drug related diabetes. genetical diabetes.
blood glucose
Time frame: 2 weeks
No study locations are listed for this record.
Plan to share: Undecided
This study is status unknown, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.